Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Directorate Changes

23 Apr 2021 17:43

RNS Number : 5048W
Dignity PLC
23 April 2021
 

23 April 2021

Dignity plc

("Dignity" or the "Company")

Directorate Changes

Dignity plc, the UK's only listed provider of funeral related services, announces the following directorate changes following the General Meeting held yesterday.

 

Clive Whiley has ceased to be a Director of the Company and Gary Channon has been appointed as Executive Chairman, in each case with immediate effect. The Independent Non-Executive Directors, comprising Gillian Kent, Dean Moore and Paul Humphreys, have resigned from the Board, in the case of Gillian Kent and Paul Humphreys, with immediate effect. Dean Moore, given his current role as Interim Chief Financial Officer, will continue to serve as a director for his three-month notice period to enable an orderly transition.

 

Commenting on the changes, Gary Channon, Executive Chairman of Dignity plc, said:

 

"We are pleased that the resolutions proposed have been passed at the General Meeting held yesterday.

As we have said all along, we will now commence a process to appoint new Independent Non-Executive Directors including a Non-Executive Chairman. This will result in a new Board with a majority of Independent Directors.

 

We believe Dignity to be a good business with great potential, and as a Board are now focused on the future. We are very excited to unlock this value for the benefit of all shareholders, clients, employees and our wider stakeholders and look forward to engaging with all of these groups as we embark on delivering the strategy and vision for Dignity. Work is already underway and we will update shareholders in due course."

 

Gary Channon

Executive Chairman

 

This announcement is made pursuant to Listing Rule 9.6.11R.

 

Pursuant to Listing Rule 9.6.13, in 1996 whilst an employee at an international investment bank, Gary Channon was involved in a proprietary trading scheme which breached Australian securities laws and resulted in disciplinary proceedings and a fine being imposed on Mr Channon and a more senior employee, by the SFA. However, the SFA held that Mr Channon did not know or believe that the scheme was unlawful, and he at all times has retained his status as fit and proper.

 

There are no other details required to be disclosed under Listing Rule 9.6.13R.

 

 

For further information please contact:

Buchanan +44 (0)20 7466 5000

Richard Oldworth

Chris Lane

Tilly Abraham

www.buchanan.uk.com dignity@buchanan.uk.com

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAIJMFTMTITBBB
Date   Source Headline
9th Jun 201711:36 amRNSResults of AGM
31st May 20172:06 pmRNSVoting Rights and Capital
19th May 20172:10 pmRNSBlock listing Interim Review
17th May 20174:38 pmRNSDirector/PDMR Shareholding
15th May 20174:35 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSFirst quarter trading update
28th Apr 20179:08 amRNSVoting Rights and Capital
27th Apr 20177:00 amRNSNotification of Q1 Trading Update
13th Apr 20175:11 pmRNSDirector/PDMR Shareholding
13th Apr 201711:03 amRNSRelease of the 2016 Annual Report
12th Apr 20171:09 pmRNSDirector/PDMR Shareholding
7th Apr 20175:51 pmRNSDirector/PDMR Shareholding
5th Apr 20171:00 pmRNSDirector/PDMR Shareholding
5th Apr 201712:10 pmRNSDirector/PDMR Shareholding
31st Mar 201710:19 amRNSVoting Rights and Capital
21st Mar 20173:06 pmRNSDirector Declaration
16th Mar 20171:57 pmRNSDirector(s)/PDMR Shareholding
13th Mar 20173:30 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Mar 20174:55 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Mar 20177:00 amRNSPreliminary Results
1st Mar 20174:44 pmRNSAdditional Listing
28th Feb 20174:20 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
28th Feb 201710:40 amRNSVoting Rights and Capital
13th Feb 20171:00 pmRNSDirectorate Change
8th Feb 20179:45 amRNSNotification of Preliminary Results
7th Feb 20174:46 pmRNSDirectorate Change
31st Jan 201710:50 amRNSVoting Rights and Capital
9th Jan 20173:35 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
30th Dec 201611:43 amRNSVoting Rights and Capital
13th Dec 20165:10 pmRNSDirector/PDMR Shareholding
30th Nov 20168:35 amRNSBlock listing Interim Review
17th Nov 201611:41 amRNSAdditional Listing
7th Nov 20167:00 amRNSThird quarter trading update
4th Nov 20162:45 pmRNSNon-Executive Director Change
31st Oct 20169:45 amRNSVoting Rights and Capital
30th Sep 201610:45 amRNSVoting Rights and Capital
15th Sep 20169:48 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
31st Aug 201610:45 amRNSVoting Rights and Capital
17th Aug 20169:06 amRNSBlock listing Interim Review
16th Aug 201612:40 pmRNSBlock listing Interim Review
9th Aug 201612:36 pmRNSReplacement - Director/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
27th Jul 20167:00 amRNSInterim Results
28th Jun 20167:00 amRNSCompletion of acquisition of three crematoria
27th Jun 20169:30 amRNSNotification of Interim Results
17th Jun 20164:48 pmRNSDirector/PDMR Shareholding
16th Jun 20162:39 pmRNSDirector/PDMR Shareholding
10th Jun 20162:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.